Hologic INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
HOLX
Hologic INCHologic, Inc. filed an amendment to its annual report, providing detailed executive compensation, corporate governance updates, and the impact of its recent merger on equity awards.
HOLX
Hologic INCHologic, Inc. reported a 1.7% revenue increase to $4.1 billion in fiscal 2025, but net income fell 28.3% to $565.7 million, impacted by significant impairment charges and restructuring costs, as the company progresses towards a proposed acquisition by Blackstone and TPG.
HOLX
Hologic INCHologic's 2024 annual report reveals a slight decrease in product revenue, offset by growth in Breast Health and GYN Surgical, while navigating challenges in Diagnostics and Skeletal Health.